{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberConstituency=Kingston+upon+Hull+North&uin=193255", "items" : [{"_about" : "http://data.parliament.uk/resources/44535", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/44535/answer", "answerText" : {"_value" : "<p> <\/p><p>It does. Public health expertise is contributed to the New Psychoactive <br>Substances review by:<br><br>Dr Owen Bowden Jones, Consultant in Addiction Psychiatry, who is leading an <br>initiative to develop clinical knowledge summaries for New Psychoactive <br>Substances with support from Public Health England; Paul Griffiths, Head of <br>Science at the European Monitoring Centre for Drugs and Drug Addiction, who <br>received an award from the US National Institute for Drug Addiction in <br>recognition of his role in developing the knowledge base on NPS; and the drug <br>policy team at the Department of Health.<\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/28", "label" : {"_value" : "Biography information for Norman Baker"}
        }
        , "answeringMemberConstituency" : {"_value" : "Lewes"}
        , "answeringMemberPrinted" : {"_value" : "Norman Baker"}
        , "dateOfAnswer" : {"_value" : "2014-04-01", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/44535/answer/previousversion/2613", "answeringMember" : "http://data.parliament.uk/members/1530", "answeringMemberConstituency" : {"_value" : "Old Bexley and Sidcup"}
          , "answeringMemberPrinted" : {"_value" : "James Brokenshire"}
        }
        , "questionFirstAnswered" : [{"_value" : "2014-04-01T12:00:00.00Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2014-03-21", "_datatype" : "dateTime"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, for what reasons the expert panel for the review into new psychoactive substances does not include representation from the public health sector.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
      , "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
      ], "uin" : "193255"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}